Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure. Humeres C, Shinde AV, Hanna A, Alex L, et al. J Clin Invest 2022;132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Humeres C, Shinde AV, Hanna A, Alex L, et al. Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure. J Clin Invest 2022;132.
PMID: 34905511